Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Alligator Bioscience AB ( (SE:ATORX) ) has shared an announcement.
Alligator Bioscience AB has announced additional subscription undertakings and guarantee commitments for its upcoming rights issue, increasing the total commitments from approximately SEK 78 million to SEK 91 million. This financial support from both existing and new investors, including Roxette Photo SA, Magnus Petersson, and HDF Impact BV, strengthens the company’s ability to advance its mitazalimab treatment towards the market, highlighting investor confidence in Alligator Bioscience’s strategic direction.
More about Alligator Bioscience AB
Alligator Bioscience AB is a company operating in the biotechnology industry, focusing on the development of innovative antibody-based therapies for cancer treatment.
YTD Price Performance: -95.86%
Average Trading Volume: 1,226,699
Technical Sentiment Signal: Sell
Current Market Cap: SEK38.21M
See more data about ATORX stock on TipRanks’ Stock Analysis page.